MedTrace Logo

Effect of a Motor Support Program in Children With Autism

NCT07321561 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2026-01-07

No results posted yet for this study

Summary

This study examined a motor support program applied for 40 minutes, two days per week, over a period of 12 weeks in children aged 4-6 years diagnosed with autism spectrum disorder. A total of 28 children with autism spectrum disorder participated in the study, including 14 children in the experimental group and 14 children in the control group. In addition to their regular special education sessions, participants in the experimental group received the motor support program for 40 minutes, two days per week, for 12 weeks. Data collection instruments included the Gilliam Autistic Disorder Rating Scale-Second Edition, Turkish Version (GARS-2-TV), the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition, Short Form (BOT-2) for the assessment of gross motor skills, and the caregiver-completed Sensory Profile Questionnaire for the assessment of sensory-motor skills.

Conditions

Interventions

OTHER

Motor Support Program

The MSP was administered by the first researcher for 60 minutes, 2 days a week for 12 weeks at the special education center where they were studying. A special program was prepared for the first 10 weeks, and in the last 2 weeks, a choose your activity activity was conducted. During this activity, children were presented with different options consisting of the activities implemented in the first 8 weeks and were asked to choose and implement them. Within each lesson plan, at least 3 different game formats were implemented for children's gross motor skills and sensory motor skills. In the following weeks, different game formats aime

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    collaborator OTHER

  • Istanbul Aydın University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-05
Primary Completion
2024-05-10
Completion
2024-06-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07321561 on ClinicalTrials.gov